1. Home
  2. SNTI vs AIRE Comparison

SNTI vs AIRE Comparison

Compare SNTI & AIRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$1.14

Market Cap

53.6M

Sector

Health Care

ML Signal

HOLD

Logo reAlpha Tech Corp.

AIRE

reAlpha Tech Corp.

HOLD

Current Price

$0.45

Market Cap

56.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNTI
AIRE
Founded
2016
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.6M
56.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SNTI
AIRE
Price
$1.14
$0.45
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$9.00
$2.00
AVG Volume (30 Days)
4.6M
6.1M
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,149,567.00
Revenue This Year
N/A
$456.19
Revenue Next Year
$150.00
$105.16
P/E Ratio
N/A
N/A
Revenue Growth
N/A
994.18
52 Week Low
$1.04
$0.14
52 Week High
$5.10
$2.29

Technical Indicators

Market Signals
Indicator
SNTI
AIRE
Relative Strength Index (RSI) 37.38 45.45
Support Level $1.15 $0.40
Resistance Level $1.28 $0.60
Average True Range (ATR) 0.07 0.04
MACD 0.01 0.00
Stochastic Oscillator 42.00 22.19

Price Performance

Historical Comparison
SNTI
AIRE

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.

Share on Social Networks: